Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 132 Results

Intervention Indication Therapeutic Area Year Actions
Benralizumab for treating hypereosinophilic syndrome Benralizumab (Fasenra; MEDI563) Hypereosinophilic syndrome (HES) Immunology 2023 View  |  Download
BI 907828 for previously untreated advanced dedifferentiated liposarcoma BI 907828 Advanced dedifferentiated liposarcoma Sarcoma 2023 View  |  Download
Bifikafusp alfa-onfekafusp alfa neoadjuvant therapy for treating resectable stage IIIB and IIIC melanoma Daromun Melanoma Skin Cancer 2023 View  |  Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa Botaretigene sparoparvovec Retinitis pigmentosa Ophthalmology 2023 View  |  Download
Brentuximab vedotin with doxorubicin, dacarbazine and vinblastine for previously untreated late-stage classical Hodgkin lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Cabotegravir (long-acting injection) for prevention of HIV-1 infection Cabotegravir (GSK1265744) HIV-1 infection Infectious Disease 2023 View  |  Download
Cabozantinib with atezolizumab for treating metastatic castration-resistant prostate cancer after one novel hormonal therapy Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Prostate cancer Haematological Cancer and Lymphomas , Oncology 2023 View  |  Download
Cabozantinib with nivolumab and ipilimumab for previously untreated advanced or metastatic renal cell carcinoma Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) , Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2023 View  |  Download
Canagliflozin for type 2 diabetes mellitus in children and adolescents Canagliflozin (Invokana; canagliflozin hemihydrate) Type 2 diabetes Endocrine, nutritional and metabolic disorders 2023 View  |  Download
Capivasertib with fulvestrant for HR+/HER2- locally advanced or metastatic breast cancer Capivasertib , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications